TRUIST FINANCIAL CORP - IMMUNOGEN INC ownership

IMMUNOGEN INC's ticker is IMGN and the CUSIP is 45253H101. A total of 221 filers reported holding IMMUNOGEN INC in Q3 2021. The put-call ratio across all filers is 0.30 and the average weighting 0.1%.

Quarter-by-quarter ownership
TRUIST FINANCIAL CORP ownership history of IMMUNOGEN INC
ValueSharesWeighting
Q4 2021$1,387,000
+15.9%
186,910
-11.5%
0.00%0.0%
Q3 2021$1,197,000
-13.9%
211,143
+0.1%
0.00%0.0%
Q2 2021$1,390,000
-10.4%
210,968
+10.1%
0.00%
-33.3%
Q1 2021$1,552,000
+9.3%
191,593
-13.0%
0.00%0.0%
Q4 2020$1,420,000
+107.0%
220,176
+15.4%
0.00%
+200.0%
Q3 2020$686,000
+27.5%
190,728
+63.0%
0.00%0.0%
Q2 2020$538,000
+73.0%
116,978
+28.3%
0.00%0.0%
Q1 2020$311,000
-34.1%
91,185
-1.2%
0.00%0.0%
Q4 2019$472,00092,3340.00%
Other shareholders
IMMUNOGEN INC shareholders Q3 2021
NameSharesValueWeighting ↓
Redmile Group, LLC 10,906,962$69,914,0003.04%
Fernwood Investment Management, LLC 224,500$1,439,0000.77%
Telemetry Investments, L.L.C. 272,000$1,744,0000.66%
Schonfeld Strategic Advisors LLC 865,356$5,547,0000.45%
Virtus ETF Advisers LLC 53,977$346,0000.43%
Endurant Capital Management LP 210,800$1,351,0000.41%
SPHERA FUNDS MANAGEMENT LTD. 500,000$3,205,0000.38%
TWIN FOCUS CAPITAL PARTNERS, LLC 113,216$726,0000.37%
Orbimed Advisors 2,834,126$18,167,0000.23%
PINNACLE ASSOCIATES LTD 1,322,231$8,476,0000.16%
View complete list of IMMUNOGEN INC shareholders